enGene (ENGN) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ENGN Stock Alerts $14.23 -0.17 (-1.18%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media enGene Short Interest DataCurrent Short Volume22,600 sharesPrevious Short Volume72,700 sharesChange Vs. Previous Month-68.91%Dollar Volume Sold Short$359,340.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares43,580,000 sharesFloat Size8,290,000 sharesShort Percent of Float0.27%Today's Trading Volume3,342 sharesAverage Trading Volume108,379 sharesToday's Volume Vs. Average3% Short Selling enGene ? Sign up to receive the latest short interest report for enGene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENGN Short Interest Over TimeENGN Days to Cover Over TimeENGN Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. enGene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202422,600 shares $359,340.00 -68.9%0.3%0.3 $15.90 4/15/202472,700 shares $1.15 million +472.4%1.0%1.4 $15.79 3/31/202412,700 shares $215,265.00 +54.9%0.2%0.3 $16.95 3/15/20248,200 shares $138,170.00 -82.8%0.1%0.2 $16.85 2/29/202447,600 shares $702,100.00 +957.8%1.8%1.1 $14.75 2/15/20244,500 shares $70,650.00 No Change0.1%0.1 $15.70 1/31/20244,500 shares $35,280.00 No Change0.0%0.1 $7.84 ENGN Short Interest - Frequently Asked Questions What is enGene's current short interest? Short interest is the volume of enGene shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 22,600 shares of ENGN short. 0.27% of enGene's shares are currently sold short. Learn More on enGene's current short interest. What is a good short interest percentage for enGene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.27% of enGene's floating shares are currently sold short. Is enGene's short interest increasing or decreasing? enGene saw a drop in short interest in April. As of April 30th, there was short interest totaling 22,600 shares, a drop of 68.9% from the previous total of 72,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is enGene's float size? enGene currently has issued a total of 43,580,000 shares. Some of enGene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. enGene currently has a public float of 8,290,000 shares. How does enGene's short interest compare to its competitors? 0.27% of enGene's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to enGene: Arcturus Therapeutics Holdings Inc. (20.02%), Evolus, Inc. (9.69%), Bicycle Therapeutics plc (9.29%), OrthoPediatrics Corp. (6.82%), Phibro Animal Health Co. (2.76%), Pliant Therapeutics, Inc. (12.51%), Disc Medicine, Inc. (12.97%), Mind Medicine (MindMed) Inc. (22.02%), Standard BioTools Inc. (3.09%), Y-mAbs Therapeutics, Inc. (7.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short enGene stock? Short selling ENGN is an investing strategy that aims to generate trading profit from enGene as its price is falling. ENGN shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against enGene? A short squeeze for enGene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENGN, which in turn drives the price of the stock up even further. How often is enGene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENGN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Arcturus Therapeutics Short Interest Data Evolus Short Interest Data Bicycle Therapeutics Short Interest Data OrthoPediatrics Short Interest Data Phibro Animal Health Short Interest Data Pliant Therapeutics Short Interest Data Disc Medicine Short Interest Data Mind Medicine (MindMed) Short Interest Data Standard BioTools Short Interest Data Y-mAbs Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENGN) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressCollapse of the Petrodollar Colonial MetalsMissed NVDA? Buy this AI stock NOWChaikin Analytics[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap Profits